Is Medpace Stock (MEDP) Halal? A Complete Analysis

The Short Answer

Medpace stock (MEDP) is generally considered halal by most Islamic scholars and Sharia screening criteria. Medpace is one of the largest publicly-traded full-service clinical contract-research organizations (CROs) in the world, providing scientifically-driven clinical-development services to the biotechnology, pharmaceutical, and medical-device industries.

Clinical-research services, clinical-trial management, regulatory-affairs services, and biostatistics-and-data-management are unambiguously permissible at the activity level under standard Sharia methodology. The financial screen passes comfortably — Medpace operates a net-cash or very-low-leverage balance sheet.

Sharia Screening Methodology

Islamic scholars use several criteria to screen stocks:

• Business activity screen: Is the company's primary business halal?
• Debt ratio: Total debt / market cap must be under 33%
• Interest income: Interest income / total revenue must be under 5%
• Haram revenue: Revenue from haram sources must be under 5%
• Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)

Medpace's Business Activity

Medpace operates a single integrated clinical-research-services platform:

• Clinical-trial management: Phase I through Phase IV clinical-trial management, clinical-monitoring, and clinical-operations services across major therapeutic areas including oncology, metabolic disease, cardiology, central-nervous-system, anti-infective, and rare-disease research
• Regulatory and scientific services: Regulatory-affairs and regulatory-submission services, medical-writing, biostatistics-and-data-management, and pharmacovigilance-and-drug-safety services
• Laboratory services: Central-laboratory, bioanalytical-laboratory, and core-laboratory imaging services

Medpace is differentiated by its concentration on small-and-mid-sized biotechnology-and-pharmaceutical sponsors and its full-service, therapeutically-aligned operating model.

Concerns to Be Aware Of

1. Minor Interest Income

Medpace operates a net-cash or very-low-leverage balance sheet, so interest income on cash balances — rather than debt — is the principal screening consideration. Purification of a small portion of income may be advisable.

2. Biotech-Funding-Cycle Exposure

Medpace's customer base is concentrated in small-and-mid-sized biotechnology-and-pharmaceutical sponsors, so biotech-funding-cycle volatility can affect new-business bookings. This is a business-cycle consideration rather than a Sharia screen concern.

3. End-Use Product Mix

Some downstream pharmaceutical-and-biotech clients develop products with impermissible end-uses (alcohol-containing formulations or porcine-derived excipients). Under standard Sharia screening methodology, the relevant industry classification is general-purpose clinical-research-services rather than the look-through end-use product mix.

Financial Ratios (2025)

Based on Medpace's most recent financial statements:

• Total Debt / Market Cap: Well under 33% — net-cash or very-low-leverage balance sheet ✅
• Interest Income / Revenue: Verify and purify small interest-income component ⚠️
• Haram Revenue: Negligible ✅
• Business Activity: Permissible clinical-research-services ✅

Verdict from Major Screening Agencies

Medpace stock is generally screened as compliant (halal) with purification by:

• Zoya App — Compliant with purification ✅
• MSCI Islamic criteria — Generally included ✅
• Most major Sharia advisory boards — Compliant with purification of small interest-income component ✅

Bottom Line

Medpace (MEDP) is generally halal with purification for Muslim investors. The core business — clinical-research-services for the healthcare industry — is unambiguously permissible at the activity level, and the financial screen passes comfortably on a net-cash balance sheet.

For Muslim investors seeking healthcare-services exposure, MEDP sits alongside other halal-screened healthcare names like McKesson (MCK), Cardinal Health (CAH), and Becton Dickinson (BDX).